State of Wyoming’s DICE Therapeutics, Inc. Common Stock DICE Stock Holding History

State of Wyoming’s Portfolio DICE Stock Details DICE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-50	Closed	-$1K	–	2063
2022 Q2	$1K	Buy	50 +12	+32%	+$206	﹤0.01%	1824
2022 Q1	$1K	Buy	38 +6	+19%	+$107	﹤0.01%	1760
2021 Q4	$1K	Buy	+32	New	+$938	﹤0.01%	1840

Other funds holding DICE

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Northpond Ventures Bethesda, Maryland $43.7M AUM 27.27% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

SCV

Sands Capital Ventures Arlington, Virginia $421M AUM 26.25% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

DCM

Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

LGM

Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return

State of Wyoming's DICE Position: Q3 2022 in Review

State of Wyoming sold out of DICE Therapeutics, Inc. Common Stock (DICE) in Q3 2022, closing a stake of 50 shares — an estimated $1K sold.

State of Wyoming first reported a position in DICE in Q4 2021 and held it in 3 quarters. The position peaked at $1K in Q2 2022. 79 funds tracked by Wall St. Rank hold DICE as of Q3 2022.

State of Wyoming reported no remaining DICE Therapeutics, Inc. Common Stock position as of Q3 2022 after selling out during the quarter.
State of Wyoming sold 50 DICE Therapeutics, Inc. Common Stock shares in Q3 2022, an estimated $1K.
State of Wyoming first reported a position in DICE Therapeutics, Inc. Common Stock in Q4 2021 and held it in 3 quarters.
State of Wyoming's DICE Therapeutics, Inc. Common Stock position peaked at $1K in Q2 2022.
79 funds tracked by Wall St. Rank held DICE Therapeutics, Inc. Common Stock as of Q3 2022.

Based on State of Wyoming's 13F filing for Q3 2022, filed 14 Nov 2022.